Showing results (1-10 of 93) with videos related to
Sort By:
Pageof 10
Journal of Cardiovascular Pharmacology|December 20, 2007
Mechanisms of ET-1-induced endothelial dysfunctionMarc Iglarz, Martine ClozelClinical Science (London, England : 1979)|August 18, 2010
At the heart of tissue: endothelin system and end-organ damageMarc Iglarz, Martine ClozelThe Journal of Pharmacology and Experimental Therapeutics|March 29, 2018
Selective Prostacyclin Receptor Agonist Selexipag, in Contrast to Prostacyclin Analogs, Does Not Evoke Paradoxical Vasoconstriction of the Rat Femoral ArteryKeith Morrison, Franck Haag, Roland Ernst, et al.Journal of Cardiovascular Pharmacology|May 21, 2015
Vascular Effects of Endothelin Receptor Antagonists Depends on Their Selectivity for ETA Versus ETB Receptors and on the Functionality of Endothelial ETB ReceptorsMarc Iglarz, Pauline Steiner, Daniel Wanner, et al.Experimental Biology and Medicine (Maywood, N.J.)|June 3, 2006
Bosentan, sildenafil, and their combination in the monocrotaline model of pulmonary hypertension in ratsMartine Clozel, Patrick Hess, Markus Rey, et al.Life Sciences|March 4, 2014
Comparison of pharmacological activity of macitentan and bosentan in preclinical models of systemic and pulmonary hypertensionMarc Iglarz, Alexandre Bossu, Daniel Wanner, et al.The Journal of Pharmacology and Experimental Therapeutics|February 23, 2017
Endothelin ETA Receptor Blockade, by Activating ETB Receptors, Increases Vascular Permeability and Induces Exaggerated Fluid RetentionMagali Vercauteren, Frederic Trensz, Anne Pasquali, et al.The Journal of Pharmacology and Experimental Therapeutics|May 7, 2017
Selexipag Active Metabolite ACT-333679 Displays Strong Anticontractile and Antiremodeling Effects but Low β-Arrestin Recruitment and Desensitization PotentialJohn Gatfield, Katalin Menyhart, Daniel Wanner, et al.Annals of Medicine|January 8, 2004
Effects of bosentan on cellular processes involved in pulmonary arterial hypertension: do they explain the long-term benefit?Martine ClozelScience Translational Medicine|January 29, 2011
Between confidentiality and scientific exchange: the place of publication in drug discovery and pharmaceutical researchMartine ClozelPageof 10